|
US6852496B1
(en)
|
1997-08-12 |
2005-02-08 |
Oregon Health And Science University |
Methods of screening for agents that promote nerve cell growth
|
|
US5968921A
(en)
*
|
1997-10-24 |
1999-10-19 |
Orgegon Health Sciences University |
Compositions and methods for promoting nerve regeneration
|
|
WO2000003737A2
(en)
|
1998-07-17 |
2000-01-27 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Water-soluble drugs and methods for their production
|
|
US6747055B1
(en)
|
1998-07-17 |
2004-06-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-soluble drugs and methods for their production
|
|
JP2002531512A
(ja)
*
|
1998-12-07 |
2002-09-24 |
エコスマート テクノロジーズ，インコーポレーテッド |
天然植物精油を用いた癌治療薬配合物および方法
|
|
EP1322307B1
(en)
*
|
2000-07-28 |
2011-09-28 |
Sloan-Kettering Institute For Cancer Research |
Methods for treating cell proliferative disorders and viral infections
|
|
US7439359B2
(en)
*
|
2000-11-02 |
2008-10-21 |
Sloan-Kettering Institute For Cancer Research |
Small molecule compositions for binding to hsp90
|
|
AU2002228772B2
(en)
|
2000-11-02 |
2005-12-08 |
Sloan Kettering Institute For Cancer Research |
Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors
|
|
AU2002252179A1
(en)
*
|
2001-03-01 |
2002-09-19 |
Conforma Therapeutics Corp. |
Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
|
|
AU2002310065B2
(en)
*
|
2001-05-23 |
2007-07-05 |
Sloan Kettering Institute For Cancer Research |
Method of treatment for cancers associated with elevated HER 2 levels
|
|
US20090197852A9
(en)
*
|
2001-08-06 |
2009-08-06 |
Johnson Robert G Jr |
Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor
|
|
US6872715B2
(en)
*
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
|
EP1923061A1
(en)
|
2001-09-24 |
2008-05-21 |
Conforma Therapeutic Corporation |
Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
|
|
CN100378079C
(zh)
*
|
2001-09-24 |
2008-04-02 |
康福玛医药公司 |
用于制备17-烯丙基氨基格尔德霉素(17-aag)以及其它袢霉素的方法
|
|
US7261875B2
(en)
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
|
ATE433961T1
(de)
*
|
2002-02-08 |
2009-07-15 |
Conforma Therapeutics Corp |
Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
|
|
CA2481683A1
(en)
*
|
2002-04-10 |
2003-10-23 |
Conforma Therapeutics Corporation |
Ansamycin formulations and methods for producing and using same
|
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
|
US20050054625A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
|
|
US20050020557A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
|
|
US20050026893A1
(en)
*
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
|
US20050020534A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
|
|
US7691838B2
(en)
*
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
|
US20050054589A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
|
|
US7241754B2
(en)
*
|
2003-06-13 |
2007-07-10 |
Kosan Biosciences, Inc. |
2-Desmethyl ansamycin compounds
|
|
CN100404029C
(zh)
*
|
2003-09-25 |
2008-07-23 |
中国医学科学院医药生物技术研究所 |
格尔德霉素（c-3559）在制备疱疹病毒生殖道感染药物中的应用
|
|
JP4717003B2
(ja)
|
2003-11-12 |
2011-07-06 |
コーサン バイオサイエンシーズ， インコーポレイテッド |
１１−ｏ−メチルゲルダナマイシン化合物
|
|
US6855705B1
(en)
|
2003-11-12 |
2005-02-15 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
|
US6887993B1
(en)
|
2003-11-12 |
2005-05-03 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
|
US6875863B1
(en)
|
2003-11-12 |
2005-04-05 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
|
US20060019941A1
(en)
*
|
2003-12-23 |
2006-01-26 |
Infinity Pharmaceuticals, Inc. |
Analogs of benzoquinone-containing ansamycins and methods of use thereof
|
|
US7282493B2
(en)
|
2003-12-23 |
2007-10-16 |
Infinity Pharmaceuticals, Inc. |
Analogs of benzoquinone-containing ansamycins and methods of use thereof
|
|
WO2005072766A2
(en)
*
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides that bind to hsp90 proteins
|
|
WO2006034147A2
(en)
*
|
2004-09-16 |
2006-03-30 |
Abraxis Bioscience, Inc. |
Compositions and methods for the preparation and administration of poorly water soluble drugs
|
|
US20060067953A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Conforma Therapeutics Corporation |
Oral pharmaceutical formulations and methods for producing and using same
|
|
KR20080004550A
(ko)
|
2005-03-30 |
2008-01-09 |
콘포마 세러퓨틱스 코포레이션 |
Ｈｓｐ９０-억제제로서 알키닐 피롤로피리미딘 및 관련유사체
|
|
EP1871361A2
(en)
*
|
2005-04-07 |
2008-01-02 |
Conforma Therapeutics Corporation |
Phospholipid-based pharmaceutical formulations and methods for producing and using same
|
|
EP1874297A4
(en)
*
|
2005-04-29 |
2009-04-22 |
Kosan Biosciences Inc |
METHOD OF TREATING MULTIPLE MYELOMES USING 17AGENE OR 17-AG OR A PRODRUG OR ALL IN COMBINATION WITH A PROTEASOMIC INHIBITOR
|
|
CN101175489A
(zh)
*
|
2005-04-29 |
2008-05-07 |
高山生物科学股份有限公司 |
用17-aag或17-ag或其前药治疗多发性骨髓瘤的方法
|
|
US20080032719A1
(en)
*
|
2005-10-01 |
2008-02-07 |
Outland Research, Llc |
Centralized establishment-based tracking and messaging service
|
|
US20100279994A1
(en)
*
|
2005-06-21 |
2010-11-04 |
Inifinity Discovery, Inc. |
Ansamycin Formulations and Methods of Use Thereof
|
|
WO2007035963A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Conforma Therapeutics Corporation |
Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors
|
|
AU2006320435A1
(en)
*
|
2005-12-01 |
2007-06-07 |
Conforma Therapeutics Corporation |
Compositions containing ansamycin
|
|
EP2054506A1
(en)
|
2006-08-15 |
2009-05-06 |
Agency for Science, Technology and Research |
Mesenchymal stem cell conditioned medium
|
|
PE20081506A1
(es)
*
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
JP2010516282A
(ja)
*
|
2007-01-26 |
2010-05-20 |
コーサン バイオサイエンシーズ， インコーポレイテッド |
工学的生合成によるマクロラクタム
|
|
BRPI0810835A2
(pt)
*
|
2007-04-12 |
2015-06-16 |
Infinity Discovery Inc |
Formulações de hidroquinona ansamicina
|
|
EP2079309B1
(en)
*
|
2007-04-12 |
2015-11-11 |
Joyant Pharmaceuticals Inc |
SMAC MIMEE DIMERS AND TRIMERS USEFUL AS ANTICANCER AGENTS
|
|
KR20100074177A
(ko)
*
|
2007-09-10 |
2010-07-01 |
유니버시티 오브 매사추세츠 |
미토콘드리아-표적화된 항-종양 물질
|
|
US7960420B2
(en)
*
|
2007-12-21 |
2011-06-14 |
Joyant Pharmaceuticals, Inc |
Diazonamide analogs with improved solubility
|
|
US20110003008A1
(en)
|
2008-02-22 |
2011-01-06 |
Agency For Science, Technology And Research (A*Star) |
Mesenchymal stem cell particles
|
|
JP2011514169A
(ja)
|
2008-03-17 |
2011-05-06 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
幹細胞培養のためのマイクロキャリア
|
|
CA2720516C
(en)
*
|
2008-04-29 |
2013-10-01 |
Joyant Pharmaceuticals, Inc. |
Indoline anti-cancer agents
|
|
US8153619B2
(en)
*
|
2008-05-22 |
2012-04-10 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs
|
|
CN102245021B
(zh)
|
2008-10-15 |
2014-09-17 |
无限药品公司 |
安莎霉素氢醌组合物
|
|
JPWO2011040421A1
(ja)
|
2009-09-29 |
2013-02-28 |
武田薬品工業株式会社 |
スクリーニング方法
|
|
US8551955B2
(en)
|
2009-10-28 |
2013-10-08 |
Joyant Pharmaceuticals, Inc. |
Dimeric Smac mimetics
|
|
US20120219632A1
(en)
|
2009-11-02 |
2012-08-30 |
Agency For Science, Technology And Research |
Methods for monitoring cellular states and for immortalizing mesenchymal stem cell
|
|
SG183579A1
(en)
|
2011-02-11 |
2012-09-27 |
Agency Science Tech & Res |
Methods of detecting therapeutic exosomes
|
|
AU2012245702B2
(en)
|
2011-04-22 |
2016-09-29 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs
|
|
WO2014055624A1
(en)
|
2012-10-02 |
2014-04-10 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Methods relating to dna-sensing pathway related conditions
|
|
CA2928568A1
(en)
|
2013-07-26 |
2015-01-29 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
WO2015140005A1
(en)
|
2014-03-19 |
2015-09-24 |
Ifom Fondazione Istituto Firc Di Oncologia Molecolare |
Method of generation of pluripotent cells
|
|
US20190231694A1
(en)
|
2016-10-12 |
2019-08-01 |
Agency For Science, Technology And Research |
Method for lyophilising an exosome
|